Pharmaceutical market of Ukraine: realities and perspectives

Pharmaceutical market of Ukraine: realities and perspectives

19.06.2017 Analytics

In 2013, which experts call the reference, the volume of the pharmaceutical market of Ukraine was about 3.3 billion US dollars. The Pharmaceutical market at that time was one of the fastest growing and took the second place among the CIS countries. According to the consulting company BakerTilly, on average, the market growth rate was 15-20%.

Despite the fact that the past, 2016, gradually returns positions, it is not possible to repeat record in dollar equivalent yet. Nevertheless, the market continue to grow confidently in UAH terms. There is a lion’s share of medicines in the pharmacy basket of retail sales. According to the results of 2016 (data of the apteka.ua portal), the volume of sales of medicines was UAH 50.5 billion per 1 billion of packs. There is a 1.98 billion in dollar equivalent. It is 21.9% more than in previous year in monetary equivalent and 5.7% in real terms. Experts point out that in 2016 the influence of the inflationary component has decreased significantly.

In January- April 2017, according to the report of “Business Credit” company, pharmacy sales in Ukraine have already increased by 16% in monetary terms (to UAH 21,335 billion) compared to the same period in 2016. The report notes that in physical terms, the volume of pharmacy sales for the same period increased by 9% (to 497, 665 million packs). The average weighted price of goods of the pharmacy basket in April this year was 43 UAH, for medicines there was 56.3 UAH per package.

On what to earn?

According to the statistical indicators of the pharmaceutical market in the national currency of Ukraine, we observe a gradual stable growth. But there is only from one side. The market volume in dollar shows that the situation looks somewhat different.

In recent years, taking into account the crisis phenomes and rising cost of life in general, there is a reduction in the purchasing power of consumers. And although the State Committee of Commerce tells us that nominal and real incomes of the population are growing, we understand that in conjunction with other factors that affect purchasing power of consumers, they can not afford more than, for example in 2013. Several years in a row, the consumer prefers cheap drugs or even tries to do without them. Only at the end of the last year and at the beginning of this year there has resumed tendency when consumer began to return to medicines of the middle and highest price categories.

Manufacturers of pharmaceutical products also do not receive excess profits lately, as it was before. In spite of the advantage of Ukrainian manufacturers to foreigners in the percentage of units of products that Ukrainians buy, most of the raw material base is imported. And it has a significant influence on price. In order to increase the sales of its products in such market, the manufacturer is forced to spend large funds on the advertising of medicines. Significant advertising costs, as market profile shows, is the most effective engine sales for today. Those who have enough money for expensive advertising and effective work with pharmacy network, “own” the market.

As for pharmacies, they are also waiting for hard times. Taking into account the low purchasing power of citizens, the state began actively regulate commercial markups. According to the latest Government initiative, a new regulation of commercial markups is set at 5% and 15%. In addition, the reference pricing is introduced. The Ministry of Health establishes reference prices for medicines, within the limits of which the selling-off price for certain medicines is determined.

Pharmacy networks respond that instead, citizens’ expenses on medicines in Ukraine are the smallest among neighbor countries, and the average weighted retail markup decreases under the pressure of market mechanisms. They indicate that the final cost of drugs depends not on pharmacy markup, but on the exchange rate. The state respond that it understands the rigidity of its steps, but emphasizes that all the steps are aimed primarily at patients, because today the market of medicines is 86% financed from the patient’s pocket.

In addition, the Ministry of Health actively promotes reimbursement of the cost of medicines for a limited list determined by international non-proprietary names. It is planed to allocate budget funds to this item. But in the market of medicines, the amount of funds allocated for reimbursement is less than 1% of consumption. In addition, manufacturers note that the principles and rules for such reimbursement have not approved yet.

Foreign competition

Despite the tendency of recent years, when domestic pharmaceutical manufacturers win positions from foreign ones, the situation may change again with the beginning of 2017. The new procedure for registration of foreign medicines came into force: producers of drugs already certified in other countries will be able to obtain permission for their importation and sale under a rather shortened procedure. In fact, it will be in verifying the registration data in the country of its receipt. Earlier manufacturers spent up to two years on it. It is expected that this will reduce prices for imported medicines and increase competition in this area with domestic producers. In addition, there are medicines that are simply not produced in Ukraine. In response, Ukrainian pharmaceutical companies initiated the consideration by the Antimonopoly Committee of Ukraine of the following question: how will updating of these registration procedures affect the competition in the Ukrainian pharmaceutical market.

According to Proxima Research data, the last year the percentage ratio in monetary equivalent of domestic and foreign producers was from 37% to 63% in favor of foreign, with a tendency of stable growth in the percentage of domestic producers. On the other hand, the shares in sales by packaging were distributed differently: 27% for imported, 73% for domestic. Here is an undoubted significant advantage on the side of Ukrainian medicines.

Cinsumer re-orientes 

As noted before, the tendency to a decrease in the proportion of drugs in the consumer’s shopping basket is gradually changing. The economy is growing, purchasing power is increasing and the consumer is confidently returning the opportunity to increase expenditures on medicines. The average price of a pharmacy basket, which is already the smallest among neighbor countries, is gradually begins to increase. In addition, the domestic consumer during the crisis has already got used to the fact that Ukrainian medicines are also qualitative and competitive. The tendency to shift the center of consumer confidence to the drugs of large domestic producers is beginning.

Forecast or the market

Pharmaceutical experts are optimistic about the future, predicting its growth in monetary terms by 14-18% in 2017. In packages, the growth is forecasted at 2.9%. Exactly the increase in consumption in physical terms and the continuation of the redistribution of consumption patterns towards more expensive medicines will be the tendency of the following periods.

Other articles

Read also

Pharmaceutical market of Ukraine: realities and perspectives
News

The Court of Appeal withdrew the arrest of the GREENSTONE’s property

The judicial panel on criminal cases of the Kiev Court of Appeal March 16, 2016 considered and settled  the appeal, canceling the seizure of property of  the GREENSTONE group of companies: “Petroprodukt-Ukraine”, “Yagotynske HPP”, “Protein-Production” and “League “. This was said in the press release. At the request of the investigator of the National Police – […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Ukrzaliznytsia ordered consultations from Deutsche Bahn for one million euros

The Kyiv Electric Car Repair Plant, owned by Ukrzaliznytsia, has entered into an agreement with DB Engineering & Consulting GmbH, a subsidiary of the German state company Deutsche Bahn, for business and management consulting services worth 1.08 million euros. Nashi Groshi reported this with reference to the data in the Prozorro system. It is noted […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Tesla has more than doubled its supply of electric vehicles in a year

Tesla published statistics on cars produced and delivered in the first quarter of 2021. According to the company, it produced 180,338 cars in three months, delivered 184,800 cars to buyers. For comparison: for the same period in 2020, Tesla produced 102,672 cars, delivered – 88,400. During the year, production and deliveries increased by almost 76% […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

The “Interhim” Odessa pharmaceutical company invested 42 million UAH in its production

The “Interhim” pharmaceutical company has completed the construction of laboratory and manufacturing facility in Odessa. Besides, the company has invested in increasing of production capacities. This step will allow the company to increase 4 times its production. At the beginning of May  2016 the total investment  is  42 million euros. The number of new jobs […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

The new Ukrainian airline has registered two aircraft

The new Ukrainian low-cost carrier Bees Airline registered its first two aircraft in Ukraine – a Boeing 737-800. “This is a Boeing 737-800 with flight numbers of the Ukrainian register UR-UBA and UR-UBB. The State Aviation Service issued registration certificates for them on February 22 and 23, 2021,” the statement reads. It is noted that […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Gasoline went up quietly

Already in the first days of 2017 tariffs on gasoline and diesel fuel have risen slightly. Such data are provided by leading Ukrainian company Consulting Group A-95, which conducts professional study of the market of petroleum products. Prices for gasoline and diesel fuel rose within 1.6%, and liquefied petroleum gas, on the other hand, fell […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Who will become the new manager of Novus?

Ukrainian Network of supermarkets Novus gets a new CEO in the person of Mark Petkevich. His predecessor, Ihor Landa is leaving the post. The new ruler of Novus Ukraine, which has held the position of executive director of the network since September 2015, will enter the status of the General on January 19 this year. […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Boeing will refine the Dreamliner aircraft

Boeing has identified the need to refine the 787 Dreamliner aircraft, which are awaiting delivery to customers – it will take some time. This is stated in the company’s quarterly report. Production of the Boeing 787 will be less than five units per month for some time and will gradually return to a monthly level […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Shell cuts spending by $15 billion

Bad news for oil industry workers and suppliers: Royal Dutch Shell has joined the ranks of energy companies who are slashing their spending. Shell said it was scaling back its planned capital investment by $15 billion over the next three years. Oil is now trading around $45 per barrel, down from over $100 per barrel […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Two bankrupt banks try to return on the market

A head of the National bank of Ukraine appeals to law enforcements  with the request  to inspect Soyuz and Veles banks. It returned  to work in spite of the fact that the Central Bank had decided its liquidation.  V.Gontareva informed on Thursday that  these two banks recently had renewed its work. NBU stopped its functioning […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Wizz Air has canceled about 20 routes from Ukraine till March 2021

Hungarian airline Wizz Air reduces the number of flights from Ukraine in the winter flight schedule. This was reported by lowcostavia. Dozens of flights from Ukraine were reduced – 12 routes are canceled by March 2021, even more destinations are temporarily suspended until the end of October. Flights from all cities of Ukraine have changed. […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Ukraine and Austria started the Bilateral Cultural Year

In 2019, Ukraine and Austria hold the Bilateral Cultural Year. Its official opening and the launch of the website austriaukraine2019.com took place on 22 February in Kyiv. The ceremony and the reception were attended by diplomats and cultural influencers of both countries. The Bilateral Cultural Year in Ukraine was inaugurated by Ambassador Extraordinary and Plenipotentiary […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

State part of Cherkassyoblenergo to sell in one package

The government committee has approved the sale of 71% of shares of PJSC Cherkassyoblenergo by one package.According to Delo.ua web-site, Igor Bilous, the head of the State Property Fund (FGI) reported about it. He says: “The decision on the merge of share blocks has been made, concerning Cherkassyoblenergo. We will sell the integrated packet of […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

The main state-owned companies of Ukraine will have observers

By the end of this year, the ministry is going to form all the Supervisory Boards. Ministry of Economic Development and Trade (MEDT) plans to appoint the independent Supervisory boards for the 15 largest public companies in Ukraine before the end of this year. This was reported by Yulia Kovalev, Deputy Minister. “The Ministry of […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

The National Bank has not been on the interbank market for six weeks

Last working week, the National Bank, as in the previous five weeks, did not buy or sell currency on the interbank market. This is evidenced by NBU data. In total, since the beginning of the year, the regulator has bought $ 290.5 million on the interbank market and sold $ 70 million. In 2020, the […]

Next
Pharmaceutical market of Ukraine: realities and perspectives
News

Megafon Company entered into a deal with Mail.ru

Russian operator MegaFon made a deal with Mail.ru shareholders to acquire a controlling stake shares of the corporation. According to official information, the purchase of securities was effected by signing the agreements with companies such as New Media and Technology Investment LP, New Media Technologies Capital Partners Limited and Ardoe Finance Limited, who are the […]

Next
WP2Social Auto Publish Powered By : XYZScripts.com